Guangshengtang: Novel Coronavirus Oral Small Molecule Innovative Drug GST-HG171 Approved for Clinical Trials


2022-09-26: [Chinese Article Link] The company e News, Open House (300436) was announced in the evening of 25 September that on 23 September the company's Innovative Drug Control Company, Inc., received from the National Pharmacy Authority, a circular on the approval of clinical trials for drugs for the innovative drug GST-HG171, an oral


Note: This is a machine translated version of the Chinese news media article. A mature and nuanced reading is suggested.




Trending in China

What China Reads


Guangshengtang: Novel Coronavirus Oral Small Molecule Innovative Drug GST-HG171 Approved for Clinical Trials


2022-09-26: [Article Link] The company e News, Open House (300436) was announced in the evening of 25 September that on 23 September the company's Innovative Drug Control Company, Inc., received from the National Pharmacy Authority, a circular on the approval of clinical trials for drugs for the innovative drug GST-HG171, an oral

Note: This is a translated version of the Chinese news media article. A mature and nuanced reading is suggested.